Clinical Evaluation of Nuclear Matrix Protein-22 (NMP-22) as a Novel Marker for Urothelial Cancer.
Suzy Hafez Abd El Halim El Mahdawy;
Abstract
Bladder cancer is the most common cancer in Egypt and the fourth in men world wide. Bladder cancer is more common in male than in females. Several factors are involved in the development of bladder cancer including bilharzial cystitis, smoking, occupation
Other data
| Title | Clinical Evaluation of Nuclear Matrix Protein-22 (NMP-22) as a Novel Marker for Urothelial Cancer. | Authors | Suzy Hafez Abd El Halim El Mahdawy | Keywords | Clinical Evaluation of Nuclear Matrix Protein-22 (NMP-22) as a Novel Marker for Urothelial Cancer. | Issue Date | 2008 | Description | Bladder cancer is the most common cancer in Egypt and the fourth in men world wide. Bladder cancer is more common in male than in females. Several factors are involved in the development of bladder cancer including bilharzial cystitis, smoking, occupation |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.